A.I.R

Welcome to the Brand page for “A.I.R”, which is offered here for Human and veterinary pharmaceutical preparations, in particular for the prevention and treatment of cancer, infectious diseases, and immunological diseases, in particular by way of nucleic acids, amplifying nucleic acids, viruses, viral like particles, peptides and proteins;pharmaceutical and veterinary information leaflets; printed pamphlets, brochures, manuals, books, booklets, leaflets, flyers, informational sheets and newsletters for providing medical, pharmaceutical, and scientific research information;air;active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines, in particular nucleic acids, amplifying nucleic acids, peptides and proteins for laboratory use;medical services, in particular, providing therapies and vaccination approaches for treating and preventing cancer, infectious diseases and immunological diseases; veterinary services, in particular, providing therapies and vaccination approaches for treating and preventing cancer, infectious diseases, and immunological diseases; medical, veterinary and pharmaceutical consultation; medical and veterinary diagnostic testing, monitoring and reporting services;providing scientific research information, consultancy, and advisory services, medical research information, consultancy, and advisory services, in particular in the fields of treatment and prevention of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases for humans or animals; providing medical research information, consultancy, and advisory services, in particular in the fields of treatment and prevention of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases;.

Its status is currently believed to be active. Its class is unavailable. “A.I.R” is believed to be currently owned by “BIONTECH RNA PHARMACEUTICALS GMBH”.